Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Mater Sci Eng C Mater Biol Appl ; 86: 28-41, 2018 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-29525094

RESUMO

The application of non-toxic carriers to increase drug loading, multi-drug delivery, and extremely small size of nano-drugs to construct a tremendous transmission system is the goal for all researchers to be pursued. The proposal of natural pectin nano-platform for delivery of multiple drugs is critical for biomedical research, especially a particle size of below 100nm with high yield. Here we design a new core-shell structure pectin-eight-arm polyethylene glycol-ursolic acid/hydrooxycampothecin nanoparticle (Pec-8PUH NPs) through a special self-assembly method for stabilizing and dispersing particles, improving water-solubility, and achieving drug controlled release. The obtained Pec-8PUH NPs possessed appropriate size (~91nm), drug-loaded efficiency and encapsulation efficiency through the regulation of eight-arm polyethylene glycol. In addition, Pec-8PUH NPs could enhance cell cytotoxicity, shorten blood retention time (7.3-fold UA, 7.2-fold HCPT) and more effective cellular uptake than free drugs, which exhibited an obvious synergistic effect of UA and HCPT by the co-delivery. 4T1 tumor-bearing mice also showed a higher survival rate than free UA and free HCPT. The result further shows that this novel drug delivery system has a promising potential for anti-cancer combination therapy.


Assuntos
Antineoplásicos/química , Portadores de Fármacos/química , Nanopartículas/química , Pectinas/química , Polietilenoglicóis/química , Animais , Antineoplásicos/metabolismo , Antineoplásicos/uso terapêutico , Camptotecina/análogos & derivados , Camptotecina/química , Camptotecina/metabolismo , Camptotecina/uso terapêutico , Linhagem Celular Tumoral , Sobrevivência Celular , Portadores de Fármacos/toxicidade , Liberação Controlada de Fármacos , Feminino , Meia-Vida , Hemólise/efeitos dos fármacos , Humanos , Camundongos , Camundongos Endogâmicos BALB C , Nanopartículas/toxicidade , Neoplasias/tratamento farmacológico , Neoplasias/patologia , Tamanho da Partícula , Transplante Heterólogo , Triterpenos/química , Triterpenos/metabolismo , Ácido Ursólico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA